Grant ID | RP170752 |
Awarded On | August 16, 2017 |
Title | Radiation-Induced Release of Chemotherapeutic Agents in Vivo |
Program | Academic Research |
Award Mechanism | High Impact/High Risk |
Institution/Organization | The University of Texas at Dallas |
Principal Investigator/Program Director | Jeremiah Gassensmith |
Cancer Sites | All Sites |
Contracted Amount | $200,000 |
Lay Summary |
Cancers deep within the body are difficult to treat and once a cancer spreads from its original location, it becomes even harder to treat. Chemotherapy is used to address this issue because the body can distribute drugs nearly everywhere, meaning it can get treat cancers deep within the body. Unfortunately, chemotherapy also kills healthy cells, and when it is delivered like that, it is delivered throughout the body where it causes many of its well-known side effects, some of which can be life threatening. Recent work has focused on using light (usually a bright light bulb or a laser) to specifically release drugs right inside the tumor (called drug delivery), resulting in more chemotherapy ... |